Changing 14-year trends in the epidemiology of hepatitis B virus infection in rural and urban Central-Eastern European areas

Journal of Viral Hepatitis

Volumn 22, Issue 12, 2015, Pages 1061-1067

  Genowska, A ^a   Jamiolkowski J ^a   Rodakowska, E ^a   Fryc, J ^a   Kozela, M ^b   Pajak A ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

HBV infection; health inequalities; incidence; rural urban areas; trends

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HEPATITIS B; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; RESIDENTIAL AREA; RURAL AREA; TREND STUDY; URBAN AREA; EPIDEMIC; GROWTH, DEVELOPMENT AND AGING; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; MIDDLE AGED; RURAL POPULATION; SEX RATIO; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; URBAN POPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; DISEASE OUTBREAKS; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLAND; RURAL POPULATION; SEX DISTRIBUTION; TREATMENT OUTCOME; URBAN POPULATION; YOUNG ADULT;

EID: 84945449457     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12420     Document Type: Article

References (34)

1. Hope V, Eramova I, Capuro D, Donoghoe M,. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect 2014; 142 (2): 270-286.
2. Ott J, Stevens G, Groeger J, Wiersma S,. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30 (12): 2212-2219.
3. Czarkowski M, Rosińska M,. Wirusowe zapalenie wątroby typu B w 2005 roku. Przegl Epidemiol 2007; 61 (2): 273-279.
4. Park S,. Trends in the seroprevalence of hepatitis B surface antigen in the South Korean population. Int J Infect Dis 2012; 16 (9): e669-e672.
5. Ergunay K, Balaban Y, Cosgun E, et al,. Epidemiologic trends in HBV infections at a reference centre in Turkey: an 11-year retrospective analysis. Ann Hepatol 2012; 11 (5): 672-678.
6. Polish Legal Act. Ustawa z dnia 5 grudnia 2008 r. o zapobieganiu oraz zwalczaniu zakażeń i chorõb zakaźnych u ludzi (Dz. U. z 2013 r. poz. 947).
7. World Health Organization. Global Policy Report on the Prevention and Control of Viral Hepatitis in WHO Member States. Geneva: WHO, 2013.
8. Magdzik W,. Hepatitis B epidemiology in Poland, Central and Eastern Europe and the Newly Independent States. Vaccine 2000; 18: S13-S16.
9. Rantala M, van de Laar M,. Surveillance and epidemiology of hepatitis B and C in Europe-a review. Euro Surveill 2008; 13 (21): pii=18880.
10. Magdzik W, Czarkowski M,. Sytuacja epidemiologiczna wirusowego zapalenia wątroby typu B w Polsce w latach 1979-2004. Przegl Epidemiol 2006; 60 (3): 471-480.
11. Katoła-͆wiątek D,. Epidemiologia przewlekłych wirusowych zapaleń wątroby typu B i C oraz nowo wykrytych zakażeń HBV i HCV w powiecie lubińskim w latach 2008-2012. Probl Hyg Epidemiol 2013; 94 (3): 551-554.
12. Matejuk A, Simon K,. Wirusowe zapalenie wątroby typu B w wojewõdztwie opolskim w latach 2001-2010. Hyg Publ Health 2012; 47 (2): 231-235.
13. Glõwny Urzad Statystyczny. Obszary wiejskie. Powszechny Spis Rolny. Olsztyn: GUS, 2013.
14. Farmer J, Munoz S, Threlkeld G,. Theory in rural health. Aust J Rural Health 2012; 20 (4): 185-189.
15. Eberhardt M, Pamuk E,. The importance of place of residence: examining health in rural and non rural areas. Am J Public Health 2004; 94 (10): 1682-1686.
16. Schifano F,. Is urbanization a risk factor for substance misuse? Curr Opin Psychiatry 2008; 21 (4): 391-397.
17. Rada C,. Sexual behaviour and sexual and reproductive health education: a cross-sectional study in Romania. Reprod Health 2014; 11: 48.
18. Narodowy Instytut Zdrowia Publicznego-Państwowy Zaklad Higieny oraz Głõwny Inspektorat Sanitarny. Choroby zakaźne i zatrucia w Polsce. Warszawa: NIZP-PZH, GIS. Roczne biuletyny za lata, 1999 -2012.
19. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) Version for 2010. Available at: http://apps.who.int/classifications/icd10/browse/2010/en#/II. (accessed 25 October 2014).
20. Kim H, Fay M, Feuer E, Midthune D,. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19 (3): 335-351 (correction: 2001; 20: 655).
21. Stępień M, Czarkowski M,. Hepatitis B in Poland in 2011. Przegl Epidemiol 2013; 67 (2): 239-245.
22. Lin H, Wang L, Hu C, et al,. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 2003; 69 (4): 471-474.
23. Ay P, Torunoglu M, Com S, et al,. Trends of hepatitis B notification rates in Turkey, 1990 to 2012. Euro Surveill 2013; 18 (47): pii:20636.
24. European Monitoring Centre for Drugs and Drug Addiction. Country overview: Poland. Available at: http://www.emcdda.europa.eu/publications/country-overviews/pl (accessed 25 October 2014).
25. Czarkowski M, Rosińska M, Sadkowska-Todys M,. Zachorowania na choroby zakaźne i pasoźytnicze. In:, Wojtyniak B, Goryński P, Moskalewicz B, eds. Sytuacja zdrowotna ludnos̈ci Polski i jej uwarunkowania. Warszawa: NIZP-PZH, 2012: 195-223.
26. Salleras L, Bruguera M, Vidal J, et al,. Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents. Eur J Epidemiol 1992; 8 (5): 640-644.
27. Garcia-Fulgueiras A, Tormo M, Rodriguez T, Perez-Flores D, Chirlaque D, Navarro C,. Prevalence of hepatitis B and C markers in the south-east of Spain: an unlinked community-based serosurvey of 2,203 adults. Scand J Infect Dis 1996; 28 (1): 17-20.
28. Neaigus A, Gyarmathy V, Zhao M, Miller M, Friedman S,. Des Jarlais D. Sexual and other noninjection risk for HBV and HCV seroconversions among noninjecing heroin users. J Infect Dis 2007; 195 (7): 1052-1061.
29. Gogos C, Fouka K, Nikiforidis G, et al,. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol 2003; 18 (6): 551-557.
30. Vilibic-Cavlek T, Kucinar J, Ljubin-Sternak S, et al,. Prevalence of viral hepatitis in Croatian adult population undergoing routine check-up, 2010-2011. Cent Eur J Public Health 2014; 22 (1): 29-33.
31. Kim H, Shin A, Chung H, et al,. Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med 2013; 28 (4): 413-419.
32. Magdzik W, Gałązka A,. Zakażenia wirusem HBV w placõwkach służby zdrowia w Polsce i zapobieganie im. Przegl Epidemiol 1997; 51 (3): 225-228.
33. Godala M, Szatko F,. Zgłaszalnos̈c chorõb zakaźnych. Cz. I. Ocena s̈wiadomos̈ci lekarzy dotycząca zgłaszania chorõb zakaźnych do inspekcji sanitarnej. Probl Hig Epidemiol 2010; 91 (2): 198-205.
34. Godala M, Szatko F,. Zgłaszalnos̈c chorõb zakaźnych. Cz. II. Bariery ograniczające pełną zgłaszalnos̈c chorõb zakaźnych do inspekcji sanitarnej w ocenie lekarzy podstawowej opieki zdrowotnej. Probl Hig Epidemiol 2010; 91 (2): 206-213.